Randomized Controlled Trial
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 21, 2015; 21(23): 7305-7312
Published online Jun 21, 2015. doi: 10.3748/wjg.v21.i23.7305
Table 3 Subgroup analyses: 5th day complete response
I: rSK schedule AII: rSK schedule BIII: HydrocortisoneP value1
Type of acute event
Without thrombosis42/48 (87.5)36/41 (87.8)10/37 (27.0)< 0.0001
With thrombosis114/122 (93.4)119/129 (92.2)36/133 (27.1)< 0.0001
Thrombectomy2/122 (1.6)2/129 (1.6)14/133 (10.5)< 0.001
Hemorrhoid classification
External96/103 (93.2)100/112 (89.3)19/112 (17.0)< 0.0001
Internal + mixed60/67 (89.6)55/58 (94.8)27/58 (46.6)< 0.0001
Prolapse grade
 I or II49/54 (91)35/37 (95)21/43 (49)< 0.0001
III or IV11/13 (85)20/21 (95)6/15 (40)< 0.001

  • Citation: Hernández-Bernal F, Castellanos-Sierra G, Valenzuela-Silva CM, Catasús-Álvarez KM, Martínez-Serrano O, Lazo-Diago OC, Bermúdez-Badell CH, Causa-García JR, Domínguez-Suárez JE, Investigators PALST4(OHWRSAGO. Recombinant streptokinase vs hydrocortisone suppositories in acute hemorrhoids: A randomized controlled trial. World J Gastroenterol 2015; 21(23): 7305-7312
  • URL: https://www.wjgnet.com/1007-9327/full/v21/i23/7305.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v21.i23.7305